[1] M. Atmaca, M. Kuloglu, E. Tezcan, B. Ustundag and N. Kilic, “Nizatidine for the Treatment of Patients with Quetiapine-Induced Weight Gain,” Hum Psychopharmacol, Vol. 19, No. 1, 2004, pp. 37-40. doi:10.1002/hup.477
[2] PRNewswire, “Eli Lilly and Company and Reliant Pharmaceuticals Announce Agreement for U.S. Sales and Marketing Rights to Axid (R),” Indianapolis, September 7, 2000.
[3] F. Parente and G. B. Porro, “Acid Inhibitory Characteristics of Nizatidine in Man: An Overview,” Scandinavian Journal of Gastroenterology, Vol. 29, No. s206, 1994, pp. 3-7. doi:10.3109/00365529409091413
[4] The United States Pharmacopoeia 32 National Formulary 27. (USP)
[5] European Pharmacopoeia 4.2, Council of Europe, 2002, pp. 2737-2739.
[6] U. D. Neue, D. McCabe, V. Ramesh, H. Pappa, J. DeMuth, “Transfer of HPLC Procedures to Suitable Columns of Reduced Dimensions and Particle Sizes,” Pharmacopeial Forum, Vol. 35, No. 6, 2009, pp.1622-1626.
[7] International Conference on Harmonization (ICH), “Stability Testing of New Drug Substances and Products,” ICH Topic Q1A (R2), ICH Secretariat, Geneva, 2005.
[8] International Conference on Harmonization (ICH), “Photostability Testing of New Drug Substances and Products,” ICH Q1B Guidline, ICH Secretariat, Geneva, 2005.
[9] S. W. Baertschi, K. Alsante and R. A. Reed, “Pharmaceutical Stress Testing: Predicting Drug Degradation,” Drugs and the Pharmaceutical Sciences, Vol. 153, 2005, pp. 1-482. doi:10.1201/9780849359194.ch3
[10] US FDA guidance, “Analytical Procedures and Methods Validation,” Food and Drug Administration, Rockville, 2000.
[11] The United States Pharmacopeial Convention, “Validation of Compendial Methods <1225>,” The United States Pharmacopeia, Rockville, 2009.
[12] M. E. Swartz and I. S. Krull, “Developing and Validating Stability-Indicating Methods by Michael Swartz and Ira Krull,” LC-GC North America, 2005.
[13] International Conference on Harmonization (ICH), “Validation of Analytical Procedures: Text and Methodology,” Q2 (R1), ICH Secretariat, Geneva, 2005.
[14] J. Ermer and J. H. McB. Miller, “Method Validation in Pharmaceutical Analysis: A Guide to Best Practice,” Wiley-VCH, enero, 2005.
[15] D. M. Bliesner, “Validating Chromatographic Methods: A Practical Guide,” Wiley, Hoboken, 2006, pp.1-304.